Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 4499

Sort by

Sort Order Select

Journal Articles

One step at a time

Hélène Schoemans, Per Ljungman

Blood (2021) 138 (14): 1208–1209.

https://doi.org/10.1182/blood.2021013434

Published: 2021

Journal Articles

STING and transplantation: can targeting this pathway improve outcomes?

Cameron S. Bader, Lei Jin, Robert B. Levy

Blood (2021) 137 (14): 1871–1878.

https://doi.org/10.1182/blood.2020008911

Published: 2021

Journal Articles

Microbiome markers are early predictors of acute GVHD in allogeneic hematopoietic stem cell transplant recipients

Raffaella Greco, Rosamaria Nitti, Nicasio Mancini, Renée Pasciuta, Francesca Lorentino, Maria Teresa Lupo-Stanghellini, Maria Chiara Barbanti, Nicola Clementi, Fabio Giglio, Daniela Clerici, Sarah Marktel, Andrea Assanelli, Matteo G. Carrabba, Massimo Bernardi, Consuelo Corti, Jacopo Peccatori, Massimo Clementi, Fabio Ciceri

Blood (2021) 137 (11): 1556–1559.

https://doi.org/10.1182/blood.2020007158

Published: 2021

Journal Articles

CD4 + T-cell reconstitution predicts survival outcomes after acute graft-versus-host-disease: a dual-center validation

Blood (2021) 137 (6): 848–855.

https://doi.org/10.1182/blood.2020007905

Published: 2021

Includes: Supplemental data

Journal Articles

Sirolimus with CSP and MMF as GVHD prophylaxis for allogeneic transplantation with HLA antigen–mismatched donors

Brian Kornblit, Barry E. Storer, Niels S. Andersen, Michael B. Maris, Thomas R. Chauncey, Effie W. Petersdorf, Ann E. Woolfrey, Mary E. D. Flowers, Rainer Storb, David G. Maloney, Brenda M. Sandmaier

Blood (2020) 136 (13): 1499–1506.

https://doi.org/10.1182/blood.2020005338

Published: 2020

Includes: Supplemental data

Journal Articles

How I treat relapsed or refractory AML

Susan DeWolf, Martin S. Tallman

Blood (2020) 136 (9): 1023–1032.

https://doi.org/10.1182/blood.2019001982

Published: 2020

Journal Articles

The microbe-derived short-chain fatty acids butyrate and propionate are associated with protection from chronic GVHD

Blood (2020) 136 (1): 130–136.

https://doi.org/10.1182/blood.2019003369

Published: 2020

Includes: Supplemental data

Journal Articles

How I treat CMV reactivation after allogeneic hematopoietic stem cell transplantation

Hermann Einsele, Per Ljungman, Michael Boeckh

Blood (2020) 135 (19): 1619–1629.

https://doi.org/10.1182/blood.2019000956

Published: 2020

Journal Articles

Clonal hematopoiesis in donors and long-term survivors of related allogeneic hematopoietic stem cell transplantation

Steffen Boettcher, C. Matthias Wilk, Jochen Singer, Fabian Beier, Elodie Burcklen, Christian Beisel, Monica S. Ventura Ferreira, Elise Gourri, Christoph Gassner, Beat M. Frey, Urs Schanz, Radek C. Skoda, Benjamin L. Ebert, Tim H. Brummendorf, Niko Beerenwinkel, Markus G. Manz

Blood (2020) 135 (18): 1548–1559.

https://doi.org/10.1182/blood.2019003079

Published: 2020

Includes: Supplemental data

Journal Articles

Oral brincidofovir decreases the incidence of HHV-6B viremia after allogeneic HCT

Joshua A. Hill, W. Garrett Nichols, Francisco M. Marty, Genovefa A. Papanicolaou, Thomas M. Brundage, Randall Lanier, Danielle M. Zerr, Michael J. Boeckh

Blood (2020) 135 (17): 1447–1451.

https://doi.org/10.1182/blood.2019004315

Published: 2020

Includes: Supplemental data

Journal Articles

Baseline TP53 mutations in adults with SCD developing myeloid malignancy following hematopoietic cell transplantation

Jack Y. Ghannam, Xin Xu, Irina Maric, Laura Dillon, Yuesheng Li, Matthew M. Hsieh, Christopher S. Hourigan, Courtney D. Fitzhugh

Blood (2020) 135 (14): 1185–1188.

https://doi.org/10.1182/blood.2019004001

Published: 2020

Journal Articles

The double-edged sword of AlloHCT for SCD

Adetola A. Kassim

Blood (2020) 135 (14): 1083–1085.

https://doi.org/10.1182/blood.2020005118

Published: 2020

Journal Articles

High-parametric evaluation of human invariant natural killer T cells to delineate heterogeneity in allo- and autoimmunity

Tom Erkers, Bryan J. Xie, Laura J. Kenyon, Brian Smith, Mary Rieck, Kent P. Jensen, Xuhuai Ji, Marina Basina, Samuel Strober, Robert S. Negrin, Holden T. Maecker, Everett H. Meyer

Blood (2020) 135 (11): 814–825.

https://doi.org/10.1182/blood.2019001903

Published: 2020

Includes: Supplemental data

Journal Articles

Is there an optimal conditioning for older patients with AML receiving allogeneic hematopoietic cell transplantation?

Stefan O. Ciurea, Piyanuch Kongtim, Ankur Varma, Gabriela Rondon, Julianne Chen, Samer Srour, Qaiser Bashir, Amin Alousi, Rohtesh Mehta, Betul Oran, Uday Popat, Chitra Hosing, Amanda Olson, Naval Daver, Marina Konopleva, Richard E. Champlin

Blood (2020) 135 (6): 449–452.

https://doi.org/10.1182/blood.2019003662

Published: 2020

Includes: Supplemental data

Journal Articles

Impact of NPM1 / FLT3 -ITD genotypes defined by the 2017 European LeukemiaNet in patients with acute myeloid leukemia

Blood (2020) 135 (5): 371–380.

https://doi.org/10.1182/blood.2019002697

Published: 2020

Includes: Supplemental data

Journal Articles

A Randomized Phase 3 Trial of Blinatumomab Vs. Chemotherapy As Post-Reinduction Therapy in High and Intermediate Risk (HR/IR) First Relapse of B-Acute Lymphoblastic Leukemia (B-ALL) in Children and Adolescents/Young Adults (AYAs) Demonstrates Superior Efficacy and Tolerability of Blinatumomab: A Report from Children's Oncology Group Study AALL1331

Patrick A. Brown, MD, Lingyun Ji, PhD, Xinxin Xu, MS, Meenakshi Devidas, PhD, Laura Hogan, MD, Michael J. Borowitz, MD PhD, Elizabeth A. Raetz, MD, Gerhard Zugmaier, Elad Sharon, MD MPH, Lia Gore, MD, James A. Whitlock, MD, Michael A. Pulsipher, MD, Stephen P. Hunger, MD, Mignon L. Loh, MD

Blood (2019) 134 (Supplement_2): LBA-1.

https://doi.org/10.1182/blood-2019-132435

Published: 2019

Journal Articles

Treatment of Refractory Acute Myeloid Leukemia and High-Grade Myelodysplastic Syndrome: Implications of Further Care at an Academic Center Versus Community Setting

Noam E. Kopmar, MD, Megan Othus, PhD, Kelda Gardner, PA-C, Carole M. Shaw, BA, Anna B. Halpern, MD, Bart L. Scott, MD, Paul C. Hendrie, MD PhD, Roland B. Walter, MDPhDMS, Pamela S. Becker, MD PhD, Elihu H. Estey, MD, Mary-Elizabeth M. Percival, MD

Blood (2019) 134 (Supplement_1): 2214.

https://doi.org/10.1182/blood-2019-123315

Published: 2019

Journal Articles

Integrated Immune Signature Analyses Identifies Evolution of Distinct Immunoregulatory Cell Populations Which Control Alloreactivity after Allogeneic HSCT

James Aries, Sarah Charrot, Jennifer Ball, Matthew Mee, Symeon Theocharidis, Sofie Van Gassen, Sameena Iqbal, John G. Gribben, MD DSc, Jeff Davies, MBBS, PhD

Blood (2019) 134 (Supplement_1): 595.

https://doi.org/10.1182/blood-2019-124875

Published: 2019

Journal Articles

Antibiotic Exposures and Dietary Intakes Are Associated with Changes in Microbiota Compositions in Allogeneic Hematopoietic Stem Cell Transplant Patients

Chi L. Nguyen, BA, Antonio L.C. Gomes, PhD, Jonathan U. Peled, MD PhD, John B. Slingerland, BSc, Ann E. Slingerland, BSc, Marissa L. Buchan, MS, Peter A. Adintori, MS, RD, CDN, Kate A Markey, PhDMBBS,FRACP, Annelie Clurman, BA, Molly A. Maloy, MS, Sergio A. Giralt, MD, Miguel-Angel Perales, MD, Ying Taur, MD MPH, Xavier B. Joao, PhD, Eric G. Pamer, MD, Marcel R.M. van den Brink, MD PhD

Blood (2019) 134 (Supplement_1): 597.

https://doi.org/10.1182/blood-2019-130578

Published: 2019

Journal Articles

The Impact of Hematopoietic Stem Cell Transplantation on Work and Productivity Loss in Patients with Acute Leukemia: Results from a Rapid Review

Tayler Scory, MSc, Eileen Shaw, MSc, Tara Cowling, MSc, Francois Peloquin, MSc, Verna L Welch, PhD MPH, Majed Charaan, MSc, MBA, Andrew Brown, PhD

Blood (2019) 134 (Supplement_1): 5829.

https://doi.org/10.1182/blood-2019-121814

Published: 2019

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

One step at a time

STING and transplantation: can targeting this pathway improve outcomes?

Microbiome markers are early predictors of acute GVHD in allogeneic hematopoietic stem cell transplant recipients

CD4 + T-cell reconstitution predicts survival outcomes after acute graft-versus-host-disease: a dual-center validation

Sirolimus with CSP and MMF as GVHD prophylaxis for allogeneic transplantation with HLA antigen–mismatched donors

How I treat relapsed or refractory AML

The microbe-derived short-chain fatty acids butyrate and propionate are associated with protection from chronic GVHD

How I treat CMV reactivation after allogeneic hematopoietic stem cell transplantation

Clonal hematopoiesis in donors and long-term survivors of related allogeneic hematopoietic stem cell transplantation

Oral brincidofovir decreases the incidence of HHV-6B viremia after allogeneic HCT

Baseline TP53 mutations in adults with SCD developing myeloid malignancy following hematopoietic cell transplantation

The double-edged sword of AlloHCT for SCD

High-parametric evaluation of human invariant natural killer T cells to delineate heterogeneity in allo- and autoimmunity

Is there an optimal conditioning for older patients with AML receiving allogeneic hematopoietic cell transplantation?

Impact of NPM1 / FLT3 -ITD genotypes defined by the 2017 European LeukemiaNet in patients with acute myeloid leukemia

Treatment of Refractory Acute Myeloid Leukemia and High-Grade Myelodysplastic Syndrome: Implications of Further Care at an Academic Center Versus Community Setting

Integrated Immune Signature Analyses Identifies Evolution of Distinct Immunoregulatory Cell Populations Which Control Alloreactivity after Allogeneic HSCT

Antibiotic Exposures and Dietary Intakes Are Associated with Changes in Microbiota Compositions in Allogeneic Hematopoietic Stem Cell Transplant Patients

The Impact of Hematopoietic Stem Cell Transplantation on Work and Productivity Loss in Patients with Acute Leukemia: Results from a Rapid Review

Email alerts

ASH Publications

American Society of Hematology